SCHEMBL22411005

SCHEMBL22411005

COc1ccc2c(c1)cc(N1CC(C)N(C)C(C)C1)n2C(=O)Nc1cccc(Cl)c1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 6/20 0.57
HTR1B P28222 6/20 0.57
HTR1A P08908 2/20 0.57
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
MAPK14 Q16539 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 2/20 0.39
MAPT P10636 4/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 3/20 0.39
TP53 P04637 3/20 0.39
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CXCR2 P25025 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604746 0.73 HTR1B (0.66) HTR1DHTR1BHTR1AKMT2AMEN1
SCHEMBL6604742 0.73 HTR1B (0.66) HTR1DHTR1BHTR1AKMT2AMEN1
SCHEMBL6605824 0.73 HTR1B (1.00) HTR1DHTR1BHTR1A
SCHEMBL6604404 0.70 HTR1B (0.82) HTR1DHTR1BHTR1AMAPTCYP3A4
SCHEMBL6604399 0.70 HTR1B (0.82) HTR1DHTR1BHTR1AMAPTCYP3A4
SCHEMBL6606934 0.70 HTR1D (0.72) HTR1DHTR1BHTR1AKMT2AGAA
SCHEMBL6606931 0.70 HTR1D (0.72) HTR1DHTR1BHTR1AKMT2AGAA
SCHEMBL6604606 0.69 HTR1B (0.78) HTR1DHTR1BHTR1AMAPTCYP3A4
SCHEMBL6604602 0.69 HTR1B (0.78) HTR1DHTR1BHTR1AMAPTCYP3A4
SCHEMBL6607001 0.68 HTR1B (0.77) HTR1DHTR1BHTR1AMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 WO disclosed